Skip to Content Skip to Search

Serbia

We are a science-led global healthcare company with a special purpose to help people do more, feel better, live longer.

Our business in Serbia focusses on bringing prescription medicines, vaccines and consumer healthcare products to patients and consumers. We are focused on making our products available through responsible pricing and strategic access programs and partnerships. We make continuous efforts to secure access for patients in Serbia to receive the latest GSK innovative therapeutic options.

Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers in Serbia and make GSK a brilliant place to work. We make a positive contribution to the communities by making partnerships and cross-functional cooperation. In cooperation with partners from our community, our company provides support to different programs that raise awareness about prevention and control of various diseases and actively participates in a large number of humanitarian actions. For our contribution to different CSR programs, our company is recognised with over 10 national awards in Serbia.

Contact information

GlaxoSmithKline Export Ltd.
Representative Office
Omladinskih brigada 88
11070 Belgrade
Serbia
Tel: +381 11 31 05 700
Fax: +381 11 31 05 799
Email: serbia_info@gsk.com

Reporting an adverse event

Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.

Tel: +381 11 31 05 700
Email: pv.serbia@gsk.com

Careers

Search for jobs in Serbia

General media enquiries

Tel: +381 11 31 05 700
Email: Serbia.Communications@gsk.com

Healthcare professionals

Health professionals in Serbia can obtain information about products and areas of therapy related to GSK by visiting GSKPro.

EFPIA Disclosure

GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations. We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.

We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations. Click here to see our disclosure report for Serbia, Europe and the rest of the world.